A Multicenter, Open-Label, Single-Arm Phase 1/2 Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants with Neurofibromatosis Type 1.
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Neurofibromatosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined